U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980584) titled 'Study on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension' on April 27.
Brief Summary: Through a randomized controlled trial (RCT) design, this study aiming to evaluated the efficacy and safety of rituximab lymph node injection combined with pulmonary vascular interventional therapy in treating fibrosing mediastinal pulmonary hypertension (FM-PH).Eligible participants were randomly assigned to either the combined treatment group, receiving both pulmonary vascular intervention and rituximab lymph node injection, or the interventional-only group, which received pulmonary vascular intervention alone. At 3, 6, and 12 mon...